Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer
Following successful precision and timing accuracy phases, the next step is a comprehensive evaluation of the web application versus the Microsoft Excel template. Testing with clinical data ensures robustness. Documentation and training for medical physicists are essential. Implementation will start...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/61333/ http://eprints.usm.my/61333/1/Haziq%20Asyraaf%20Shafizan-E.pdf |
| _version_ | 1848884682314219520 |
|---|---|
| author | Shafizan, Haziq Asyraaf |
| author_facet | Shafizan, Haziq Asyraaf |
| author_sort | Shafizan, Haziq Asyraaf |
| building | USM Institutional Repository |
| collection | Online Access |
| description | Following successful precision and timing accuracy phases, the next step is a comprehensive evaluation of the web application versus the Microsoft Excel template. Testing with clinical data ensures robustness. Documentation and training for medical physicists are essential. Implementation will start with a pilot group, followed by full-scale deployment. Evaluation of BED and EQD2 values reveals minimal deviations, indicating high comparability. For target tissue, BED deviation is 0.048% and EQD2 is 0.008%. The bladder shows a BED deviation of 0.055% and EQD2 of 0.073%. The rectum has a BED deviation of 0.014% and EQD2 of 0.029%. For the sigmoid, the BED deviation is 0.035% and EQD2 is 0.142%. All deviations are within the 3% tolerance limit. The web application completes the full treatment in 138.69 seconds, compared to 202.67 seconds for Excel, with a TER of 1.46. For the first additional patient, the web application takes 96.84 seconds, while Excel takes 107.11 seconds, giving a TER of 1.11. For the second additional patient, the web application takes 94.77 seconds versus 78.66 seconds for Excel, with a TER of 0.83. Despite occasional exceptions, the web application is generally more time-efficient and reliable. |
| first_indexed | 2025-11-15T19:10:35Z |
| format | Thesis |
| id | usm-61333 |
| institution | Universiti Sains Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-15T19:10:35Z |
| publishDate | 2024 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | usm-613332024-11-14T02:14:27Z http://eprints.usm.my/61333/ Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer Shafizan, Haziq Asyraaf R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) RC870-923 Diseases of the genitourinary system. Urology Following successful precision and timing accuracy phases, the next step is a comprehensive evaluation of the web application versus the Microsoft Excel template. Testing with clinical data ensures robustness. Documentation and training for medical physicists are essential. Implementation will start with a pilot group, followed by full-scale deployment. Evaluation of BED and EQD2 values reveals minimal deviations, indicating high comparability. For target tissue, BED deviation is 0.048% and EQD2 is 0.008%. The bladder shows a BED deviation of 0.055% and EQD2 of 0.073%. The rectum has a BED deviation of 0.014% and EQD2 of 0.029%. For the sigmoid, the BED deviation is 0.035% and EQD2 is 0.142%. All deviations are within the 3% tolerance limit. The web application completes the full treatment in 138.69 seconds, compared to 202.67 seconds for Excel, with a TER of 1.46. For the first additional patient, the web application takes 96.84 seconds, while Excel takes 107.11 seconds, giving a TER of 1.11. For the second additional patient, the web application takes 94.77 seconds versus 78.66 seconds for Excel, with a TER of 0.83. Despite occasional exceptions, the web application is generally more time-efficient and reliable. 2024-07 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/61333/1/Haziq%20Asyraaf%20Shafizan-E.pdf Shafizan, Haziq Asyraaf (2024) Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer. Masters thesis, Universiti Sains Malaysia. |
| spellingShingle | R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) RC870-923 Diseases of the genitourinary system. Urology Shafizan, Haziq Asyraaf Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer |
| title | Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer |
| title_full | Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer |
| title_fullStr | Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer |
| title_full_unstemmed | Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer |
| title_short | Evaluation of high-dose rate (HDR) radiobiologic dose-equivalent web tool for cervical cancer |
| title_sort | evaluation of high-dose rate (hdr) radiobiologic dose-equivalent web tool for cervical cancer |
| topic | R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) RC870-923 Diseases of the genitourinary system. Urology |
| url | http://eprints.usm.my/61333/ http://eprints.usm.my/61333/1/Haziq%20Asyraaf%20Shafizan-E.pdf |